Search…

Revenue Cockpit

Helix Instruments · Helix Instruments · revenue-forecasting cockpit, as of 29 May 2026. Bottoms-up pipeline reconciled to a top-down model, priced as a closeable gap to plan.

FP&A + CRO read
Pilot
LIVEData as of 29 May 2026, 16:42 · last feed run 11 min ago
FY forecast $811.0M — $29.0M short of the $840.0M plan. $24.0M of the gap (83%) is controllable.7 need you
FY forecast
$811.0M
plan $840.0M
$29.0M below the $840.0M plan — see the split below.
Q2 commit
$197.9M
Q2 plan $205.8M
This quarter’s number — the one you’re graded on next, behind the Q2 plan.
Backlog coverage
88%
contracted ÷ forecast
88% of the number is already contracted; pipeline has to carry the rest.
Pipeline coverage
0.7×
target 2.4× (1 ÷ win-rate)
Open pipeline vs remaining plan, against the win-rate-implied target.
Win rate
42%
actual, volume-weighted
The conversion behind every pipeline dollar — it sets the coverage you need.
Forecast accuracy
95%
1 − WAPE, volume-weighted
Last cycle’s realized accuracy — the credibility behind today’s call.
The agent’s read

I reconcile bottoms-up and top-down to $811.0M (±1.7%) — $29.0M short of your $840.0M plan.

Pipeline (bottoms-up) calls $807.8M; the driver model (top-down) says $835.0M. The reconciled number sits in the middle. $24.0M of the $29.0M gap is controllable — the levers below — and only $5.0M is structural (FX, hard supply, calendar). Here are the moves that close the controllable part.

You’re $29.0M short of the $840.0M plan — $24.0M you can fix, $5.0Myou can’t.

Can fix · $24.0M (83%)
Can’t · $5.0M
Consumables mix shiftfix
$12.0M
→ re-mix / push instrument attach
Flagship discountingfix
$7.0M
→ tighten deal-desk discount tier
APAC region-mixfix
$5.0M
→ re-weight quota / pricing
Q4 supply capcan't
$3.0M
→ escalate — hard ceiling, cannot sell past it
EMEA FXcan't
$2.0M
→ hedge — not sellable

Close the $24.0M controllable and you land within $5.0M of plan — the rest is structural (FX, hard supply, calendar) and gets a band, not a lever.

Pacing to plan — cumulative, business-day indexedFY · cumulative
Actual Forecast PlanShortfall to plan
$222.6M$445.2M$667.8M$890.4MJanFebMarAprMayJunJulAugSepOctNovDecMay 29$840.0M$811.0M

Tracking $29.0M below plan through year-end — the wedge is the gap accumulating.

Forecast fragilitydiversified
11%of the to-go number rests on the top 5 deals
top 1 = 2%everything else = 89%
If Equinox Diagnostics D — channel slips out of period, you miss by $2.8M.
Equinox Diagnostics D — channel
$2.8M2%
Tessera Instruments — channel
$2.6M2%
Meridian Biosciences — MX-9 fleet expansion
$2.5M2%
Halcyon Technologies D — renewal
$2.3M2%
Nimbus Systems C — channel
$2.3M2%
What moved this weekvs last forecast
−$9.7Mnet WoW
$820.7M → $811.0M
  • re-weightedHelios Biosciences — channel−$159K
  • slippedNorthwind Materials A — renewal−$149K
  • slippedProbe Therapeutics E — channel−$66K
  • re-weightedNimbus Systems C — channel−$63K
  • slippedSentient Systems — channel−$59K

What the agent is flagging

Understand the build →
Forecast agent reading
Mixed
FY26 reconciles to $811M — $29M short of the $840M plan.
The read
For the CFO read — $24M of the gap is controllable; only $5M (FX + the hard Q4 supply cap) is structural.
Driving it
A consumables mix shift ($12M), flagship discounting ($7M), and an APAC region-mix drag ($5M) carry the controllable shortfall.
Watch
If the Q4 supply cap on the flagship instrument tightens further, the structural piece grows.
Sourced fromCOCRM — open pipeline·TDTop-down driver model
watch78% conf

Two-thirds of the gap is the consumables mix shift — and it is controllable.

Volume is healthy; realized margin is diluting as the book tilts to lower-margin consumables.

watch74% conf

EMEA has run ~+6% optimistic three quarters running.

The EMEA commit is systematically high; I haircut it by 6% in the reconciled number.

Next: how the number is built, and the full levered gap decomposition